<?xml version="1.0" encoding="UTF-8"?>
<ref id="B56-molecules-25-04737">
 <label>56.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Felding</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>SÃ¸rensen</surname>
    <given-names>M.D.</given-names>
   </name>
   <name>
    <surname>Poulsen</surname>
    <given-names>T.D.</given-names>
   </name>
   <name>
    <surname>Larsen</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Andersson</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Refer</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Engell</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Ladefoged</surname>
    <given-names>L.G.</given-names>
   </name>
   <name>
    <surname>Thormann</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Vinggaard</surname>
    <given-names>A.M.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Discovery and Early Clinical Development of 2-{6-[2-(3,5-Dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a Soft-Drug Inhibitor of Phosphodiesterase 4 for Topical Treatment of Atopic Dermatitis</article-title>
  <source>J. Med. Chem.</source>
  <year>2014</year>
  <volume>57</volume>
  <fpage>5893</fpage>
  <lpage>5903</lpage>
  <pub-id pub-id-type="doi">10.1021/jm500378a</pub-id>
  <?supplied-pmid 24984230?>
  <pub-id pub-id-type="pmid">24984230</pub-id>
 </element-citation>
</ref>
